BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 2751682)

  • 1. The role of Ca2+ and protein kinase C in the differentiation of HL-60 cells induced by 1 alpha,25(OH)2D3 and diltiazem.
    Taoka T; Itano T; Tokuda M; Tanaka T; Hatase O; Irino S
    Biochem Int; 1989 Jun; 18(6):1193-201. PubMed ID: 2751682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of myelodysplastic syndrome and acute myelogenous leukemia with vitamin D3 [1 alpha(OH)D3]].
    Irino S; Taoka T
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1183-90. PubMed ID: 2837981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staurosporine, a novel protein kinase inhibitor, enhances HL-60-cell differentiation induced by various compounds.
    Okazaki T; Kato Y; Mochizuki T; Tashima M; Sawada H; Uchino H
    Exp Hematol; 1988 Jan; 16(1):42-8. PubMed ID: 2826200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of phorbol ester-induced phenotypic differentiation of HL-60 cells by 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine, a protein kinase inhibitor.
    Matsui T; Nakao Y; Koizumi T; Katakami Y; Fujita T
    Cancer Res; 1986 Feb; 46(2):583-7. PubMed ID: 3606750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,25-Dihydroxyvitamin D3 enhances cytosolic free calcium in HL-60 cells.
    Barnea E; Levy R; Zimlichman R; Shany S
    Exp Hematol; 1990 Dec; 18(11):1147-51. PubMed ID: 2226676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The involvement of calcium ions in the effect of 1,25-dihydroxyvitamin D3 on HL-60 cells.
    Levy R; Nathan I; Barnea E; Chaimovitz C; Shany S
    Exp Hematol; 1988 May; 16(4):290-4. PubMed ID: 3129299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative differentiation of human promyelocytic leukemia cells (HL-60) induced selectively by retinoic acid and 1 alpha,25-dihydroxyvitamin D3.
    Miyaura C; Abe E; Suda T; Kuroki T
    Cancer Res; 1985 Sep; 45(9):4244-8. PubMed ID: 2992776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phospholipid- and Ca2+-dependent protein kinase activity and protein phosphorylation patterns in the differentiation of human promyelocytic leukemia cell line HL-60.
    Zylber-Katz E; Glazer RI
    Cancer Res; 1985 Oct; 45(10):5159-64. PubMed ID: 3161611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maturation-dependent regulation of protein kinase C activity by vitamin D3 metabolites in chondrocyte cultures.
    Sylvia VL; Schwartz Z; Schuman L; Morgan RT; Mackey S; Gomez R; Boyan BD
    J Cell Physiol; 1993 Nov; 157(2):271-8. PubMed ID: 8227160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
    Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
    Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of calmodulin antagonists and cytochalasins on proliferation and differentiation of human promyelocytic leukemia cell line HL-60.
    Matsui T; Nakao Y; Kobayashi N; Koizumi T; Nakagawa T; Kishihara M; Fujita T
    Cancer Res; 1985 Jan; 45(1):311-6. PubMed ID: 3855282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,25-Dihydroxyvitamin D3 induced activation and subsequent nuclear translocation of MAPK is upstream regulated by PKC in HL-60 cells.
    Marcinkowska E; Wiedłocha A; Radzikowski C
    Biochem Biophys Res Commun; 1997 Dec; 241(2):419-26. PubMed ID: 9425286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition by 1alpha,25-dihydroxyvitamin D3 of activin A-induced differentiation of murine erythroleukemic F5-5 cells.
    Nagasaki T; Hino M; Inaba M; Nishizawa Y; Morii H; Otani S
    Arch Biochem Biophys; 1997 Jul; 343(2):181-7. PubMed ID: 9224728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Okadaic acid biologically mimics the role of calcium/phospholipid dependent kinase inhibitors in the process of HL-60 cell differentiation.
    Okuda T; Tashima M; Tohi T; Ogawa K; Sawada H; Okuma M
    Int J Hematol; 1993 Aug; 58(1-2):37-41. PubMed ID: 8219110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnesium deprivation inhibits the expression of differentiation-related phenotypes in human promyelocytic leukemia HL-60 cells.
    Okazaki T; Mochizuki T; Tashima M; Sawada H; Uchino H
    J Cell Physiol; 1987 Apr; 131(1):50-7. PubMed ID: 3032994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of intracellular calcium ion in human promyelocytic leukemia HL-60 cell differentiation.
    Okazaki T; Mochizuki T; Tashima M; Sawada H; Uchino H
    Cancer Res; 1986 Dec; 46(12 Pt 1):6059-63. PubMed ID: 3465433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement by 1 alpha,25-dihydroxyvitamin D3 of chemically induced transformation of BALB 3T3 cells without induction of ornithine decarboxylase or activation of protein kinase C1.
    Sasaki K; Chida K; Hashiba H; Kamata N; Abe E; Suda T; Kuroki T
    Cancer Res; 1986 Feb; 46(2):604-10. PubMed ID: 3000580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in proto-oncogene expression associated with reversal of macrophage-like differentiation of HL 60 cells.
    Studzinski GP; Brelvi ZS
    J Natl Cancer Inst; 1987 Jul; 79(1):67-76. PubMed ID: 3474450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrid structural analogues of 1,25-(OH)2D3 regulate chondrocyte proliferation and proteoglycan production as well as protein kinase C through a nongenomic pathway.
    Boyan BD; Posner GH; Greising DM; White MC; Sylvia VL; Dean DD; Schwartz Z
    J Cell Biochem; 1997 Sep; 66(4):457-70. PubMed ID: 9282324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of cell growth, differentiation, and production of interleukin-3 by 1 alpha,25-dihydroxyvitamin D3 in the murine myelomonocytic leukemia cell line WEHI-3.
    Abe J; Moriya Y; Saito M; Sugawara Y; Suda T; Nishii Y
    Cancer Res; 1986 Dec; 46(12 Pt 1):6316-21. PubMed ID: 3490908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.